The import of pacemakers for stimulating heart muscles to China is projected to witness consistent growth from 2024 to 2028. In 2023, the import value stood at $181.76 million. The forecasted figures indicate a steady year-on-year increase, with import values reaching $186.96 million in 2024 and expected to rise to $207.88 million by 2028. The compound annual growth rate (CAGR) over the 2024-2028 period is estimated to reflect a solid expansion trend.
Key future trends to watch include:
- Rising healthcare demand driven by an aging population and increasing awareness about cardiac care.
- Technological advancements enhancing the reliability and functionality of pacemakers.
- Potential regulatory changes influencing import dynamics and pricing structures.
- The impact of domestic production capabilities on import dependencies.
